Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
32 participants
INTERVENTIONAL
2018-11-27
2019-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Parents as the Agent of Change for Childhood Obesity
NCT01197443
Study of Parenting Intervention to Prevent Child Obesity
NCT00998348
Healthy Weight at Home: A Pilot Weight Loss Program for Parents of Children With a Disability
NCT04697225
Parents As The Agent Of Change For Childhood Obesity (PAAC)
NCT01066910
Healthy Homes/Healthy Kids_5-9
NCT01084590
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
In-person first session, no second caregiver, no wifi-enabled scale
In-Person First Session
Conduct first session in person vs. over the phone
Group 2
In-person first session, no second caregiver, wifi-enabled scale
In-Person First Session
Conduct first session in person vs. over the phone
WiFi-enabled Scale
Have participant weigh in weekly on a wifi-enabled scaled vs. regular scale
Group 3
In-person first session, second caregiver, no wifi-enabled scale
In-Person First Session
Conduct first session in person vs. over the phone
Second Caregiver
Have second caregiver participate in three coaching calls
Group 4
In-person first session, second caregiver, wifi-enabled scale
In-Person First Session
Conduct first session in person vs. over the phone
Second Caregiver
Have second caregiver participate in three coaching calls
WiFi-enabled Scale
Have participant weigh in weekly on a wifi-enabled scaled vs. regular scale
Group 5
No in-person first session, no second caregiver, no wifi-enabled scale. 10 core coaching calls only
10 Core Coaching Calls Only
Participant will receive 10 core phone coaching sessions
Group 6
No in-person first session, no second caregiver, wifi-enabled scale
WiFi-enabled Scale
Have participant weigh in weekly on a wifi-enabled scaled vs. regular scale
Group 7
No in-person first session, second caregiver, no wifi-enabled scale
Second Caregiver
Have second caregiver participate in three coaching calls
Group 8
No in-person first session, second caregiver, wifi-enabled scale
Second Caregiver
Have second caregiver participate in three coaching calls
WiFi-enabled Scale
Have participant weigh in weekly on a wifi-enabled scaled vs. regular scale
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
In-Person First Session
Conduct first session in person vs. over the phone
Second Caregiver
Have second caregiver participate in three coaching calls
WiFi-enabled Scale
Have participant weigh in weekly on a wifi-enabled scaled vs. regular scale
10 Core Coaching Calls Only
Participant will receive 10 core phone coaching sessions
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The child's BMI is greater than or equal to the 85th percentile according to CDC age and sex reference standards
* Child lives with parent/primary caregiver 50% of the time
* Willing to have a second caregiver participate in this study
* Wifi at home
* The parent and child can speak, read, and understand English
Exclusion Criteria
* Chromosomal abnormality such as Down's syndrome or Turner's syndrome
* Child taken any steroid medications such as Prednisone, Prenisilone and Decadron on a daily basis for more than 1 month in the past 6 months (this does not include inhalers with steroids)
* Child enrolled in a different weight management program
* Family participating in any other child research study related to dietary intake, physical activity, weight
* Plans to move more than 50 miles from your present location within the next 6 months
8 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Minnesota
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nancy Sherwood, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Minnesota
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Minnesota
Minneapolis, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY00004193
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.